Taysha Gene Therapies
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-5.99-6.93-7.20-24.97
Price/Sales ratio
18.812.882.090.85
Earnings per Share (EPS)
$-0.46$-0.40$-0.39$-0.11

Historical Multiples (2019 – 2023)

2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-798.23-10.90-2.49-0.58-1.84-0.11-6.70
Price/Sales ratio
N/AN/AN/A39.7013.3011.9619.85
Price/Book Value ratio
-6.59K1.864.59104.662.7431.543.23
Price/Cash Flow ratio
6.59K-15.25-3.74-1.12-2.81-0.18-9.50
Price/Free Cash Flow ratio
6.59K-11.77-3.16-0.87-2.55-0.14-7.47
Price/Earnings Growth ratio
N/A-0.00-0.020.030.02-0.01-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A0.59%100%N/A0.29%
Operating Profit Margin
N/AN/AN/A-6492.68%-468.83%-9780.17%-3246.34%
Pretax Profit Margin
N/AN/AN/A-6635.25%-722.06%-9991.92%-3317.62%
Net Profit Margin
N/AN/AN/A-6777.81%-722.06%-9991.92%-3388.90%
Effective Tax Rate
400%28.34%-0.53%-2.14%N/AN/A-0.26%
Return on Assets
-7433.33%-16.60%-82.00%-134.29%-64.58%-197.97%-108.15%
Return On Equity
825.92%-17.11%-183.95%-17869.44%-148.87%-1047.00%-615.47%
Return on Capital Employed
825.92%-17.08%-106.81%-255.87%-53.27%-385.43%-181.34%
Liquidity Ratios
Current Ratio
N/A36.17N/AN/AN/A1.53N/A
Quick Ratio
0.135.243.081.534.071.392.30
Cash ratio
N/A35.242.881.393.911.392.14
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/A80.86K16.14K1.60KN/AN/A8.87K
Cash Conversion Cycle
N/AN/AN/A-1.60KN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/A0.170.300.230.990.58
Debt Equity Ratio
N/AN/A0.3840.000.54132.0666.22
Long-term Debt to Capitalization
N/AN/A0.280.970.350.950.61
Total Debt to Capitalization
N/AN/A0.280.970.35N/A0.62
Interest Coverage Ratio
N/A-1.53KN/AN/AN/A-44.01N/A
Cash Flow to Debt Ratio
N/AN/A-3.14-2.32-1.80N/A-1.57
Company Equity Multiplier
-0.111.032.24133.062.30133.061.63
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-35.32-4.72-64.90-17.66
Free Cash Flow / Operating Cash Flow Ratio
11.291.181.281.101.241.23
Cash Flow Coverage Ratio
N/AN/A-3.14-2.32-1.80N/A-1.57
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A